Literature DB >> 20447835

Human Vgamma9Vdelta2 T cells: from signals to functions.

Steven Nedellec1, Marc Bonneville, Emmanuel Scotet.   

Abstract

Human Vgamma9Vdelta2 T cells, a major innate-like peripheral T cell subset, are thought to play in vivo a key role in innate and adaptive immune responses to infection agents and tumors. Vgamma9Vdelta2 T cell activation is tightly regulated by a variety of activating or inhibitory receptors which are specific for constitutively expressed or stress-modulated ligands. However, the mechanisms and signal transduction pathways regulating their broad effector functions, such as cytotoxicity and cytokine responses, remain poorly understood. Here we provide an updated overview of the activation modalities of Vgamma9Vdelta2 T cells by highlighting the respective role played by T cell receptor (TCR) versus non-TCR stimuli, and focus on recent studies showing how Vgamma9Vdelta2 T cells integrate the numerous activating and inhibitory signals and translate them into a particular effector and biological function. A better understanding of these critical issues should help optimize immunotherapeutic approaches targeting Vgamma9Vdelta2 T cells. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447835     DOI: 10.1016/j.smim.2010.04.004

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  22 in total

1.  ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation.

Authors:  Monali Manohar; Mark I Hirsh; Yu Chen; Tobias Woehrle; Anjali A Karande; Wolfgang G Junger
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

Review 2.  Current progress in γδ T-cell biology.

Authors:  Jianlei Hao; Xiaoli Wu; Siyuan Xia; Zheng Li; Ti Wen; Na Zhao; Zhenzhou Wu; Puyue Wang; Liqing Zhao; Zhinan Yin
Journal:  Cell Mol Immunol       Date:  2010-10-11       Impact factor: 11.530

Review 3.  Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.

Authors:  Ilan Bank; Victoria Marcu-Malina
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 4.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

5.  Evolution of the V, D, and J gene segments used in the primate gammadelta T-cell receptor reveals a dichotomy of conservation and diversity.

Authors:  Allison R Kazen; Erin J Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

6.  Deep sequencing of the human TCRγ and TCRβ repertoires suggests that TCRβ rearranges after αβ and γδ T cell commitment.

Authors:  Anna M Sherwood; Cindy Desmarais; Robert J Livingston; Jessica Andriesen; Maximilian Haussler; Christopher S Carlson; Harlan Robins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

7.  Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection.

Authors:  Iskra Tuero; David Venzon; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2016-11-04       Impact factor: 5.422

Review 8.  γδ T cell receptor ligands and modes of antigen recognition.

Authors:  Eric Champagne
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-02-06       Impact factor: 4.291

9.  Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.

Authors:  Emilie Lesport; Jeremy Baudhuin; Sylvie Sousa; Joel LeMaoult; Alessia Zamborlini; Nathalie Rouas-Freiss; Edgardo D Carosella; Benoit Favier
Journal:  Cell Mol Life Sci       Date:  2011-02-20       Impact factor: 9.261

Review 10.  Adoptive cell therapy for sarcoma.

Authors:  Melinda Mata; Stephen Gottschalk
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.